WILMINGTON, Delaware, Oct. 18 -- AstraZeneca, a biopharmaceutical company, issued the following news release: * * * TEZSPIRE approved in the US for chronic rhinosinusitis with nasal polyps Approval broadens indication for TEZSPIRE to a second disease characterized by epithelial-driven inflammation * AstraZeneca and Amgen's TEZSPIRE (tezepelumab -ekko) has been approved in the US for the add-on maintenance treatment of adult and pediatric patients aged 12 years and older with inadequately co  more

BOSTON, Massachusetts, Oct. 17 [Category: BizHospital] -- The Dana-Farber Cancer Institute issued the following news release: * * * Chemotherapy Combination Boosts Overall Survival in Patients with EGFR-mutant Non-Small Cell Lung Cancer * Final analysis of Dana-Farber co-led phase 3 FLAURA2 study underscore benefits of adding chemotherapy to existing standard first line therapy with an EGFR-TKI. Treatment with osimertinib plus a platinum-pemetrexed chemotherapy combination resulted in stat  more

PROVIDENCE, Rhode Island, Oct. 18 -- Gov. Daniel J. McKee, D-Rhode Island, issued the following news release on Oct. 17, 2025: * * * Governor McKee, 195 District Mark Major Milestone with New Life Sciences Building Ceremonial Ribbon Cutting Celebrates Completion of 150 Richmond * Governor Dan McKee was joined today by representatives of the 195 District and numerous dignitaries to mark the completion of the 150 Richmond building with a ceremonial ribbon-cutting. The 212,000-square-foot life  more